NCT04850846 2026-02-09
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Oxford University Hospitals NHS Trust